1. Home
  2. RVNC vs BYM Comparison

RVNC vs BYM Comparison

Compare RVNC & BYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • BYM
  • Stock Information
  • Founded
  • RVNC 1999
  • BYM 2002
  • Country
  • RVNC United States
  • BYM United States
  • Employees
  • RVNC N/A
  • BYM N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • BYM Investment Managers
  • Sector
  • RVNC Health Care
  • BYM Finance
  • Exchange
  • RVNC Nasdaq
  • BYM Nasdaq
  • Market Cap
  • RVNC 546.4M
  • BYM 312.7M
  • IPO Year
  • RVNC 2014
  • BYM N/A
  • Fundamental
  • Price
  • RVNC $5.29
  • BYM $11.77
  • Analyst Decision
  • RVNC Buy
  • BYM
  • Analyst Count
  • RVNC 10
  • BYM 0
  • Target Price
  • RVNC $10.86
  • BYM N/A
  • AVG Volume (30 Days)
  • RVNC 1.3M
  • BYM 60.2K
  • Earning Date
  • RVNC 11-06-2024
  • BYM 01-01-0001
  • Dividend Yield
  • RVNC N/A
  • BYM 4.49%
  • EPS Growth
  • RVNC N/A
  • BYM N/A
  • EPS
  • RVNC N/A
  • BYM N/A
  • Revenue
  • RVNC $251,178,000.00
  • BYM N/A
  • Revenue This Year
  • RVNC $20.36
  • BYM N/A
  • Revenue Next Year
  • RVNC $31.66
  • BYM N/A
  • P/E Ratio
  • RVNC N/A
  • BYM N/A
  • Revenue Growth
  • RVNC 40.23
  • BYM N/A
  • 52 Week Low
  • RVNC $2.30
  • BYM $9.30
  • 52 Week High
  • RVNC $9.75
  • BYM $11.77
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 44.50
  • BYM 33.09
  • Support Level
  • RVNC $5.10
  • BYM $11.91
  • Resistance Level
  • RVNC $5.43
  • BYM $11.96
  • Average True Range (ATR)
  • RVNC 0.17
  • BYM 0.07
  • MACD
  • RVNC 0.02
  • BYM -0.02
  • Stochastic Oscillator
  • RVNC 66.67
  • BYM 9.70

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About BYM Blackrock Municipal Income Quality Trust of Beneficial Interest

Blackrock Municipal Income Quality Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from U.S. federal income taxes, including the alternative minimum tax. It trust invests in various sectors such as transportation, utilities, health, education, corporate, housing and others.

Share on Social Networks: